Navigation Links
NREL teams with Navy, private industry to make jet fuel from switchgrass

The Energy Department's National Renewable Energy Laboratory (NREL) is partnering with Cobalt Technologies, U.S. Navy, and Show Me Energy Cooperative to demonstrate that jet fuel can be made economically and in large quantities from a renewable biomass feedstock such as switch grass.

"This can be an important step in the efforts to continue to displace petroleum by using biomass resources," NREL Manager for Bioprocess Integration R&D Dan Schell said. "We're converting biomass into sugars for subsequent conversion to butanol and then to JP5 jet fuel."

It's one of four biorefinery projects funded recently by the Energy Department as part of the Administration's efforts to support renewable biofuels as a domestic alternative to power military and civilian aircraft and vehicles

NREL's pretreatment reactor and enzymatic digester reactors will process switchgrass into fermentable sugars. NREL's 9,000-liter fermenters will then produce butanol from the sugars using Cobalt Technologies' proprietary microorganisms and fermentation process. A co-exclusive patent license agreement between the Navy and Cobalt Technologies is providing the technology and expertise for converting the butanol to jet fuel. Show Me Energy Cooperative of Centerville, Mo., will provide the switchgrass feedstock. Show Me Energy's headquarters also is a potential site for a new, larger biorefinery if the demonstration succeeds.

NREL will be combining its pretreatment, enzymatic hydrolysis, and fermentation expertise with Cobalt's promising microorganisms to produce the butanol intermediate, said David Sievers, R&D Engineer at NREL. Technology originating from Cobalt and the Navy will be used to turn butanol into jet fuel at the NREL biorefinery pilot plant. The process will use the Navy's unique catalyst systems.

The goal is to show that the Cobalt-Navy bio-jet fuel can be a cost competitive alternative that meets military specifications while using non-food based biomass as a feedstock, thus reducing the Department of Defense's dependence on petroleum-based products.

The results of testing will help determine whether the process is ready for commercial scale. If so, the U.S. Department of Agriculture and the Department of Defense are poised to help private firms build the huge biorefineries that would be needed, Schell said.

NREL has the equipment to convert biomass to fermentable sugars at a scale of one dry ton per day, using enzyme formulas and a dilute acid catalyzed pretreatment developed by Cobalt. Hemicellulose and cellulose sugars will be fermented simultaneously using three of NREL's 9,000 liter fermenters.

"At NREL, we can take biomass feedstock, convert it to biofuels and scale it up in our pilot plant, in this case converting it to butanol," NREL Senior Project Leader for Partnership Development Rich Bolin said. "The (test) runs we did last year with Cobalt Technologies producing butanol at our pilot plant were quite successful."

The project could lead to big gains in jet-fuel manufacturing in the United States and a boost for jobs in rural America. Using biomass rather than petroleum offers the advantages of improved energy security, less price volatility and a smaller impact on the environment, Bolin said.

The process is expected to result in a 95% reduction in greenhouse gas emissions compared to the current production of jet fuel.


Contact: David Glickson
DOE/National Renewable Energy Laboratory

Related biology news :

1. OHSU teams with Intel to decode the root causes of cancer and other complex diseases
2. Impressive list of research teams for the 2013 HFSP Research Grants
3. US, New Zealand search-and-rescue teams recalled from Antarctic plane crash site
4. Basketball teams offer insights into building strategic networks
5. Thirty teams compete to interpret three families genomes
6. Pollution teams with thunderclouds to warm atmosphere
7. ONR taps research teams to help reduce jet noise
8. New grants to innovation corps nodes further enhance public-private partnership
9. Medbox Executes $6 Million Equity Transaction with Private Investment Firm
10. USDA study shows trends in public and private agricultural R&D
11. Privately owned genetic databases may hinder diagnosis and bar the way to the arrival of personalized medicine
Post Your Comments:
(Date:11/4/2015)... , November 4, 2015 ... new market report published by Transparency Market Research "Home Security ... Trends and Forecast 2015 - 2022", the global home security ... 30.3 bn by 2022. The market is estimated to ... period from 2015 to 2022. Rising security needs among ...
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/27/2015)... Germany , October 27, 2015 ... SMI,s Automated Semantic Gaze Mapping technology (ASGM) automatically maps ... SMI,s Eye Tracking Glasses , so that they ... BeGaze. --> Munich, Germany , ... (ASGM) automatically maps data from mobile eye tracking videos ...
Breaking Biology News(10 mins):
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)... 2015 --> ... - 2020 report analyzes that automating biobanking workflow ... in long-term samples, minimizing manual errors, improving the ... manual errors such as mislabeling or inaccurate sample ... plays a vital role in blood fractionation, DNA ...
(Date:11/25/2015)... , November 25, 2015 ... cat and human plaque and pave the way for more ... problems in cats     --> ... most commonly diagnosed health problems in cats, yet relatively little ... now. Two collaborative studies have been conducted by researchers from ...
(Date:11/25/2015)... CITY , Nov. 25, 2015 /PRNewswire/ - Aeterna ... affirms that its business and prospects remain fundamentally ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB recommendation ... to completion following review of the final interim ... Phase 2 Primary Endpoint in men with heavily ...
Breaking Biology Technology: